| I-56 David Busse Analysis of target-site distribution of meropenem in morbidly obese and non-obese patients using nonlinear mixed-effects modelling Wednesday 09:50-11:15 |
| I-56 David Busse Analysis of target-site distribution of meropenem in morbidly obese and non-obese patients using nonlinear mixed-effects modelling Wednesday 09:50-11:15 |